Retinoid X Receptor α Overexpression Alleviates Mitochondrial Dysfunction-induced Insulin Resistance through Transcriptional Regulation of Insulin Receptor Substrate 1 |
Lee, Seung Eun
(Department of Internal Medicine, Seoul National University College of Medicine)
Koo, Young Do (Department of Internal Medicine, Seoul National University College of Medicine) Lee, Ji Seon (Department of Internal Medicine, Seoul National University College of Medicine) Kwak, Soo Heon (Department of Internal Medicine, Seoul National University College of Medicine) Jung, Hye Seung (Department of Internal Medicine, Seoul National University College of Medicine) Cho, Young Min (Department of Internal Medicine, Seoul National University College of Medicine) Park, Young Joo (Department of Internal Medicine, Seoul National University College of Medicine) Chung, Sung Soo (Department of Internal Medicine, Seoul National University College of Medicine) Park, Kyong Soo (Department of Internal Medicine, Seoul National University College of Medicine) |
1 | Anderson, E.J., Lustig, M.E., Boyle, K.E., Woodlief, T.L., Kane, D.A., Lin, C.T., Price, J.W., 3rd, Kang, L., Rabinovitch, P.S., Szeto, H.H., et al. (2009). Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J. Clin. Invest. 119, 573-581. DOI ScienceOn |
2 | Cesario, R.M., Klausing, K., Razzaghi, H., Crombie, D., Rungta, D., Heyman, R.A., and Lala, D.S. (2001). The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo. Mol. Endocrinol. 15, 1360-1369. |
3 | Chae, S., Ahn, B.Y., Byun, K., Cho, Y.M., Yu, M.H., Lee, B., Hwang, D., and Park, K.S. (2013). A systems approach for decoding mitochondrial retrograde signaling pathways. Sci. Signal. 6, rs4. |
4 | Egawa, K., Nakashima, N., Sharma, P.M., Maegawa, H., Nagai, Y., Kashiwagi, A., Kikkawa, R., and Olefsky, J.M. (2000). Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes. Endocrinology 141, 1930-1935. DOI |
5 | Evans, R.M., and Mangelsdorf, D.J. (2014). Nuclear receptors, RXR, and the big bang. Cell 157, 255-266. DOI ScienceOn |
6 | Fisher-Wellman, K.H., and Neufer, P.D. (2012). Linking mitohondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol. Metab. 23, 142-153. DOI ScienceOn |
7 | Gianni, M., Tarrade, A., Nigro, E.A., Garattini, E., and Rochette-Egly, C. (2003). The AF-1 and AF-2 domains of RAR gamma 2 and RXR alpha cooperate for triggering the transactivation and the degradation of RAR gamma 2/RXR alpha heterodimers. J. Biol. Chem. 278, 34458-34466. DOI ScienceOn |
8 | Gual, P., Le Marchand-Brustel, Y., and Tanti, J.F. (2005). Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87, 99-109. DOI ScienceOn |
9 | Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M., and Thaller, C. (1992). 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68, 397-406. DOI ScienceOn |
10 | Kelley, D.E., He, J., Menshikova, E.V., and Ritov, V.B. (2002). Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950. DOI ScienceOn |
11 | Kelley, D.E., and Simoneau, J.A. (1994). Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 94, 2349-2356. DOI |
12 | Kim, M., Ahn, B.Y., Lee, J.S., Chung, S.S., Lim, S., Park, S.G., Jung, H.S., Lee, H.K., and Park, K.S. (2009). The ginsenoside Rg3 has a stimulatory effect on insulin signaling in L6 myotubes. Biochem. Biophys. Res. Commun. 389, 70-73. DOI ScienceOn |
13 | Kliewer, S.A., Umesono, K., Noonan, D.J., Heyman, R.A., and Evans, R.M. (1992). Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358, 771-774. DOI ScienceOn |
14 | Macotela, Y., Emanuelli, B., Bang, A.M., Espinoza, D.O., Boucher, J., Beebe, K., Gall, W., and Kahn, C.R. (2011). Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One 6, e21187. DOI |
15 | Leibowitz, M.D., Ardecky, R.J., Boehm, M.F., Broderick, C.L., Caragna, M.A., Crombie, D.L., D'Arrigo, J., Etgen, G.J., Faul, M.M., Grese, T.A., et al. (2006). Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes. Endocrinology 147, 1044-1053. DOI ScienceOn |
16 | Lenhard, J.M., Lancaster, M.E., Paulik, M.A., Weiel, J.E., Binz, J.G., Sundseth, S.S., Gaskill, B.A., Lightfoot, R.M., and Brown, H.R. (1999). The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction. Diabetologia 42, 545-554. DOI |
17 | Lowell, B.B., and Shulman, G.I. (2005). Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387. DOI ScienceOn |
18 | Martin, S.D., and McGee, S.L. (2014). The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim. Biophys. Acta 1840, 1303-1312. DOI ScienceOn |
19 | Morino, K., Petersen, K.F., Dufour, S., Befroy, D., Frattini, J., Shatzkes, N., Neschen, S., White, M.F., Bilz, S., Sono, S., et al. (2005). Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115, 3587-3593. DOI ScienceOn |
20 | Osburn, D.L., Shao, G., Seidel, H.M., and Schulman, I.G. (2001). Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. Mol. Cell. Biol. 21, 4909-4918. DOI ScienceOn |
21 | Simoneau, J.A., and Kelley, D.E. (1997). Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 83, 166-171. |
22 | Pederson, T.M., Kramer, D.L., and Rondinone, C.M. (2001). Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 50, 24-31. DOI ScienceOn |
23 | Ritov, V.B., Menshikova, E.V., He, J., Ferrell, R.E., Goodpaster, B.H., and Kelley, D.E. (2005). Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54, 8-14. DOI ScienceOn |
24 | Ryu, H.S., Park, S.Y., Ma, D., Zhang, J., and Lee, W. (2011). The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS One 6, e17343. DOI ScienceOn |
25 | Singh, A.B., Guleria, R.S., Nizamutdinova, I.T., Baker, K.M., and Pan, J. (2012). High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling. J. Cell. Physiol. 227, 2632-2644. DOI ScienceOn |
26 | Sun, X.J., Goldberg, J.L., Qiao, L.Y., and Mitchell, J.J. (1999). Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes 48, 1359-1364. DOI ScienceOn |
27 | Yuzefovych, L.V., Solodushko, V.A., Wilson, G.L., and Rachek, L.I. (2012). Protection from palmitate-induced mitochondrial DNA damage prevents from mitochondrial oxidative stress, mitochondrial dysfunction, apoptosis, and impaired insulin signaling in rat L6 skeletal muscle cells. Endocrinology 153, 92-100. DOI |
![]() |